Approved healthcare professional labeling for MUCINEX®supports guaifenesin’s ability to help loosen phlegm and thin bronchial secretions in patients with Stable Chronic Bronchitis (SCB)†ǂ
Presenting Author: Kim KC
Study results support guaifenesin’s effect on mucin production, rheology, and mucociliary transportability in fully differentiated human epithelial cells.
*Source: Suneetha G, Venkateswarlu P, Prasad PSS. Determination of guaifensen and dextromethorphan by UPLC. Der Pharma Chemica. 2012; 4(3):1019-1025.
†Source: Drugs.com Statistics, Q4 2011 (http://www.drugs.com/stats/top100/2011/q4/sales).
ǂGuaifenesin products indicated for the treatment of stable chronic bronchitis are available only by prescription.